Yes, Discontinue Amlodipine and Switch to Alternative Antihypertensive Therapy
Amlodipine should be discontinued due to gingival hyperplasia and replaced with alternative antihypertensive agents that do not cause this adverse effect. This is a well-documented side effect of calcium channel blockers, and stopping the medication typically leads to resolution of the gingival enlargement 1.
Immediate Management Strategy
Stop amlodipine immediately and substitute with agents from different classes that preserve blood pressure control and renal protection:
First-Line Replacement Options
ACE inhibitor or ARB: These are the preferred alternatives as they provide both blood pressure control AND renal protection 2, 3, 4
- ACE inhibitors and ARBs are specifically recommended for patients requiring renal protection
- They do NOT cause gingival hyperplasia
- Examples: lisinopril, enalapril (ACE inhibitors) or losartan, valsartan (ARBs)
Thiazide-like diuretic: Can be added as second agent if needed 3, 4
- Chlorthalidone or indapamide preferred over hydrochlorothiazide
- Provides additional blood pressure reduction without gingival effects
Additional Options if Needed
- Beta-blockers: Cardioselective agents like bisoprolol or metoprolol 2, 5
- Alpha-blockers: Prazosin has been successfully used in case reports 5
Expected Timeline for Resolution
Gingival hyperplasia typically resolves within 2-6 months after discontinuing amlodipine 5, 6, 7. The improvement occurs without surgical intervention in most cases, though good oral hygiene and professional scaling should be maintained during this period 8, 9.
Critical Considerations
Why Amlodipine Must Be Stopped
The evidence is clear that gingival hyperplasia is a direct adverse effect of amlodipine 1. While this occurs in <1% of patients overall, it is well-documented and dose-related 1. The FDA drug label specifically lists gingival hyperplasia as an adverse reaction 1.
Renal Protection Is Maintained
You will NOT lose renal protection by switching from amlodipine to an ACE inhibitor or ARB. In fact, ACE inhibitors and ARBs provide superior renal protection compared to calcium channel blockers 10, 11:
- ACE inhibitors/ARBs reduce proteinuria independent of blood pressure effects
- They are specifically recommended as first-line therapy for patients with chronic kidney disease 10, 11
- Amlodipine does not have the same non-BP-mediated renal protective effects
Blood Pressure Control Strategy
If the patient was on amlodipine as part of multi-drug therapy:
- Replace amlodipine with ACE inhibitor or ARB as the cornerstone agent 3, 4
- Add thiazide-like diuretic (chlorthalidone or indapamide) if additional control needed 3, 4
- Consider beta-blocker or alpha-blocker as third agent if target BP not achieved 2, 5
Monitoring After Switch
- Check blood pressure within 1-2 weeks after medication change 2
- Monitor serum creatinine and potassium within 1-2 weeks when starting ACE inhibitor/ARB 11
- Reassess gingival hyperplasia at 2-3 months - expect significant improvement 5, 6, 7
Common Pitfall to Avoid
Do NOT restart amlodipine after the gingival hyperplasia resolves. Case reports show that reintroducing amlodipine causes recurrence of gingival enlargement, even at lower doses 7, 12. The patient in one case series had complete resolution after stopping amlodipine, but when restarted due to inadequate BP control with alternatives, the hyperplasia returned 7.
Special Note on Ciclosporin
If your patient happens to be on ciclosporin (for any reason), be aware that calcium channel blockers like amlodipine can additively worsen gingival hyperplasia when combined with ciclosporin 13. This makes discontinuation even more imperative. However, the guidelines note that ACE inhibitors and thiazide diuretics are safe alternatives for ciclosporin-induced hypertension 13.